"Study to Evaluate the Safety, Tolerability and Immunogenicity of INO-4700 for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Healthy"
2022-06-30
عنوان الدراسة
"Study to Evaluate the Safety, Tolerability and Immunogenicity of INO-4700 for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Healthy"
داعم الدراسة
Inovio Pharmaceuticals, Inc.
دواء الدراسة
NO-4700 + CELLECTRA™ 2000 (device)
رقم بروتوكول الدراسة
MERS-201
حالة الدراسة
Completed
موقع الدراسة
KSMC
مرحلة الدراسة
2
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.